Takeda Y, Kimura F, Takasawa S
    
    
    Life (Basel). 2024; 14(1).
  
  
    PMID: 38276286
    
          PMC: 10821044.
    
          DOI: 10.3390/life14010157.
      
 
                                  
  
    Okada Y, Numata T, Sabirov R, Kashio M, Merzlyak P, Sato-Numata K
    
    
    Front Cell Dev Biol. 2023; 11:1246955.
  
  
    PMID: 37842082
    
          PMC: 10576435.
    
          DOI: 10.3389/fcell.2023.1246955.
      
 
                                  
  
    Chen C, Yan W, Tao M, Fu Y
    
    
    Antioxidants (Basel). 2023; 12(6).
  
  
    PMID: 37371959
    
          PMC: 10295009.
    
          DOI: 10.3390/antiox12061230.
      
 
                                  
  
    Guse A
    
    
    Cells. 2023; 12(4).
  
  
    PMID: 36831342
    
          PMC: 9954121.
    
          DOI: 10.3390/cells12040675.
      
 
                                  
  
    Gao L, Du X, Li J, Qin F
    
    
    Br J Cancer. 2022; 128(4):492-504.
  
  
    PMID: 36396822
    
          PMC: 9938187.
    
          DOI: 10.1038/s41416-022-02052-6.
      
 
                              
              
                              
                                      
  Targeting CD38 for acute leukemia.
  
    Zhong X, Ma H
    
    
    Front Oncol. 2022; 12:1007783.
  
  
    PMID: 36313735
    
          PMC: 9597453.
    
          DOI: 10.3389/fonc.2022.1007783.
      
 
                                          
                                                          
  Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies.
  
    Mustafa N, Azaman M, Ng G, Chng W
    
    
    Biomolecules. 2022; 12(9).
  
  
    PMID: 36139103
    
          PMC: 9496523.
    
          DOI: 10.3390/biom12091261.
      
 
                                          
                                                          
  Paracrine ADP Ribosyl Cyclase-Mediated Regulation of Biological Processes.
  
    Astigiano C, Benzi A, Laugieri M, Piacente F, Sturla L, Guida L
    
    
    Cells. 2022; 11(17).
  
  
    PMID: 36078044
    
          PMC: 9454491.
    
          DOI: 10.3390/cells11172637.
      
 
                                          
                                                          
  Metabolic analyses reveal dysregulated NAD+ metabolism and altered mitochondrial state in ulcerative colitis.
  
    Kang Y, Tucker S, Quevedo S, Inal A, Korzenik J, Haigis M
    
    
    PLoS One. 2022; 17(8):e0273080.
  
  
    PMID: 35976971
    
          PMC: 9385040.
    
          DOI: 10.1371/journal.pone.0273080.
      
 
                                          
                                                          
  The crystal structure of TRPM2 MHR1/2 domain reveals a conserved Zn -binding domain essential for structural integrity and channel activity.
  
    Sander S, Pick J, Gattkowski E, Fliegert R, Tidow H
    
    
    Protein Sci. 2022; 31(6):e4320.
  
  
    PMID: 35634784
    
          PMC: 9112350.
    
          DOI: 10.1002/pro.4320.
      
 
                                          
                                                          
  CD38-Cyclic ADP-Ribose Signal System in Physiology, Biochemistry, and Pathophysiology.
  
    Takasawa S
    
    
    Int J Mol Sci. 2022; 23(8).
  
  
    PMID: 35457121
    
          PMC: 9033130.
    
          DOI: 10.3390/ijms23084306.
      
 
                                          
                                                          
  Anti CD38 monoclonal antibodies for multiple myeloma treatment.
  
    Gozzetti A, Ciofini S, Simoncelli M, Santoni A, Pacelli P, Raspadori D
    
    
    Hum Vaccin Immunother. 2022; 18(5):2052658.
  
  
    PMID: 35404740
    
          PMC: 9225612.
    
          DOI: 10.1080/21645515.2022.2052658.
      
 
                                          
                                                          
  Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies.
  
    Wu H, Zhao X
    
    
    Int J Biol Sci. 2022; 18(5):1974-1988.
  
  
    PMID: 35342342
    
          PMC: 8935232.
    
          DOI: 10.7150/ijbs.68148.
      
 
                                          
                                                          
  Okamoto model for necrosis and its expansions, CD38-cyclic ADP-ribose signal system for intracellular Ca mobilization and Reg (Regenerating gene protein)-Reg receptor system for cell regeneration.
  
    Okamoto H, Takasawa S
    
    
    Proc Jpn Acad Ser B Phys Biol Sci. 2021; 97(8):423-461.
  
  
    PMID: 34629354
    
          PMC: 8553518.
    
          DOI: 10.2183/pjab.97.022.
      
 
                                          
                                                          
  Enzymology of extracellular NAD metabolism.
  
    Gasparrini M, Sorci L, Raffaelli N
    
    
    Cell Mol Life Sci. 2021; 78(7):3317-3331.
  
  
    PMID: 33755743
    
          PMC: 8038981.
    
          DOI: 10.1007/s00018-020-03742-1.
      
 
                                          
                                                          
  Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells.
  
    Baum N, Fliegert R, Bauche A, Hambach J, Menzel S, Haag F
    
    
    Cancers (Basel). 2021; 13(1).
  
  
    PMID: 33396591
    
          PMC: 7795599.
    
          DOI: 10.3390/cancers13010076.
      
 
                                          
                                                          
  CD38 triggers inflammasome-mediated pyroptotic cell death in head and neck squamous cell carcinoma.
  
    Zhang M, Gao W, Liu S, Siu S, Yin M, Ng J
    
    
    Am J Cancer Res. 2020; 10(9):2895-2908.
  
  
    PMID: 33042624
    
          PMC: 7539785.
    
      
 
                                          
                                                          
  Clinical Evidence for Targeting NAD Therapeutically.
  
    Radenkovic D, Reason , Verdin E
    
    
    Pharmaceuticals (Basel). 2020; 13(9).
  
  
    PMID: 32942582
    
          PMC: 7558103.
    
          DOI: 10.3390/ph13090247.
      
 
                                          
                                                          
  Does Cyclic ADP-Ribose (cADPR) Activate the Non-selective Cation Channel TRPM2?.
  
    Fliegert R, Riekehr W, Guse A
    
    
    Front Immunol. 2020; 11:2018.
  
  
    PMID: 32903769
    
          PMC: 7438885.
    
          DOI: 10.3389/fimmu.2020.02018.
      
 
                                          
                                                          
  Role of CD38/cADPR signaling in obstructive pulmonary diseases.
  
    Guedes A, Dileepan M, Jude J, Deshpande D, Walseth T, Kannan M
    
    
    Curr Opin Pharmacol. 2020; 51:29-33.
  
  
    PMID: 32480246
    
          PMC: 7529733.
    
          DOI: 10.1016/j.coph.2020.04.007.